Clinical Trial Update: A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 trial evaluating the combination of pelareorep and atezolizumab in advanced anal cancer and pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Pancreatic Cancer

Drugs mentioned

• REOLYSIN (pelareorep)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified | Phase 1, Phase 2 | Status: RECRUITING